Concurrent Use of Herbal Medicines and Prescription Drugs and Potential Herb-Drug Interactions: A Cross-Sectional Study
DOI:
https://doi.org/10.68041/anjmls.v1i3/04Keywords:
Chronic Disease, Herb-Drug Interactions, Phytotherapy, Polypharmacy, Prescription Drugs, Self MedicationAbstract
Background: Herbal medicine use is widespread amongst people with chronic conditions, and this could be a potential concern for herb–drug interactions. This study aimed to evaluate the prevalence of concurrent herbal medicine use and factors associated with possible interactions among adult patients who were on long-term pharmacotherapy. Method: In this study, 220 adults attending outpatient departments at a tertiary care hospital and using prescribed medicines for ≥3 months were included. Data on chronic diseases, prescribed and herbal medicines, medication disclosure, information sources, self-medication, and adverse effects were collected through interviewer-administered questionnaires and medical records. Potential herb–drug interactions were identified using published evidence. Descriptive statistics and multivariable logistic regression were performed, with p < 0.05 considered statistically significant. Results: The mean age was 47.5 ± 13.2 years, and 58.2% were female. 96 (43,6%) of participants reported using herbs concurrently, and 28 (29.2%) disclosed that they used herbs to their physicians. 37 (38.5%) of herbal users were identified as having potential herb-drug interactions. The most frequently reported adverse effects were gastrointestinal symptoms 16 (16.7%), followed by altered glycaemic control 11 (11.5%). Independent predictors were use of three or more prescribed medicines (AOR=3.18, 95% CI: 1.45-6.98; p=0.004), physician unawareness (AOR=2.81, 95% CI: 1.18-6.69; p=0.019), age ≥60 years (AOR=2.39, 95% CI: 1.04-5.47; p=0.041), and self-medication (AOR=2.22, 95% CI: 1.01-4.91; p=0.047). Conclusion: Use of herbal medicine was widespread, often unacknowledged, and had potential interaction risks. Medication safety should be adopted through routine enquiry and pharmacist-supported medication review.
References
1. Tulunay M, Aypak C, Yikilkan H, Gorpelioglu S. Herbal medicine use among patients with chronic diseases. J Intercult Ethnopharmacol. 2015;4(3):217–220. https://doi.org/10.5455/jice.20150623090040 DOI: https://doi.org/10.5455/jice.20150623090040
2. Alzahrani AS, Price MJ, Greenfield SM, Paudyal V. Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77(9):1259–1274. https://doi.org/10.1007/s00228-021-03097-x
3. Chin JW, Abdullah R, Tan BW, Wong KW, Khor BH. Prevalence and patterns of complementary and alternative medicine usage among adults with chronic kidney disease: a systematic review and meta-analysis. J Integr Med. 2025;23(4):370–381. https://doi.org/10.1016/j.joim.2025.05.001
4. Rahimzade M, Farshbaf-Khalili A, Karimi M, Abolhasanpour N, Kazemi AH, Mirzaei M. The prevalence of herbal medicine use and related factors among diabetic patients in Tabriz, Iran, 2023: a cross-sectional study. J Diabetes Metab Disord. 2025;24(1):36. https://doi.org/10.1007/s40200-024-01531-2 DOI: https://doi.org/10.1007/s40200-024-01531-2
5. Vaou N, Stavropoulou E, Voidarou C, Tsakris Z, Rozos G, Tsigalou C, et al. Interactions between medical plant-derived bioactive compounds: focus on antimicrobial combination effects. Antibiotics (Basel). 2022;11(8):1014. https://doi.org/10.3390/antibiotics11081014 DOI: https://doi.org/10.3390/antibiotics11081014
6. Deodhar M, Al Rihani SB, Arwood MJ, Darakjian L, Dow P, Turgeon J, et al. Mechanisms of CYP450 inhibition: understanding drug–drug interactions due to mechanism-based inhibition in clinical practice. Pharmaceutics. 2020;12(9):846. https://doi.org/10.3390/pharmaceutics12090846 DOI: https://doi.org/10.3390/pharmaceutics12090846
7. Hatfield J, Saad S, Housewright C. Dietary supplements and bleeding. Proc (Bayl Univ Med Cent). 2022;35(6):802–807. https://doi.org/10.1080/08998280.2022.2121575 DOI: https://doi.org/10.1080/08998280.2022.2121575
8. Sutanto H. Tackling polypharmacy in geriatric patients: is increasing physicians’ awareness adequate? Arch Gerontol Geriatr Plus. 2025;2(3):100185. https://doi.org/10.1016/j.aggp.2025.100185 DOI: https://doi.org/10.1016/j.aggp.2025.100185
9. Romero-García PA, Ramirez-Perez S, Miguel-González JJ, Guzmán-Silahua S, Castañeda-Moreno JA, Komninou S, et al. Complementary and alternative medicine (CAM) practices: a narrative review elucidating the impact on healthcare systems, mechanisms and paediatric applications. Healthcare (Basel). 2024;12(15):1547. https://doi.org/10.3390/healthcare12151547 DOI: https://doi.org/10.3390/healthcare12151547
10. Shen C, Ren ZY, Lan HD, Kong LY, Yang M, Su YZ, et al. Perspectives, experiences, and practices of healthcare professionals and patients towards herb–drug interaction: a systematic review of qualitative studies. Phytother Res. 2025;39(1):505–520. https://doi.org/10.1002/ptr.8384 DOI: https://doi.org/10.1002/ptr.8384
11. Harsh S, Tripathi S, Venuturumilli R, Reddy GH, Mukherjee B, Lakhani HA, et al. Adverse drug reactions and drug interactions in multimorbid patients: a review of current evidence. Cureus. 2025;17(11). https://doi.org/10.7759/cureus.97640 DOI: https://doi.org/10.7759/cureus.97640
12. Ciapponi A, Fernandez Nievas SE, Seijo M, Rodríguez MB, Vietto V, García-Perdomo HA, et al. Reducing medication errors for adults in hospital settings. Cochrane Database Syst Rev. 2021;2021(11). https://doi.org/10.1002/14651858.CD009985.pub2 DOI: https://doi.org/10.1002/14651858.CD009985.pub2
13. Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009;124(3):471–474. https://doi.org/10.1177/003335490912400320 DOI: https://doi.org/10.1177/003335490912400320
14. Goodyear MDE, Krleza-Jeric K, Lemmens T. The Declaration of Helsinki. BMJ. 2007;335(7621):624–625. https://doi.org/10.1136/bmj.39339.610000.BE DOI: https://doi.org/10.1136/bmj.39339.610000.BE
15. Alzahrani AS, Price MJ, Greenfield SM, Paudyal V. Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77(9):1259–1274. https://doi.org/10.1007/s00228-021-03097-x DOI: https://doi.org/10.1007/s00228-021-03097-x
16. Chin JW, Abdullah R, Tan BWW, Wong KW, Khor BH. Prevalence and patterns of complementary and alternative medicine usage among adults with chronic kidney disease: a systematic review and meta-analysis. J Integr Med. 2025;23(4):370–381. https://doi.org/10.1016/j.joim.2025.05.001 DOI: https://doi.org/10.1016/j.joim.2025.05.001
17. Foley H, Steel A, Cramer H, Wardle J, Adams J. Disclosure of complementary medicine use to medical providers: a systematic review and meta-analysis. Sci Rep. 2019;9(1):1573. https://doi.org/10.1038/s41598-018-38279-8 DOI: https://doi.org/10.1038/s41598-018-38279-8
18. Dores AR, Peixoto M, Castro M, Sa C, Carvalho IP, Martins A, et al. Knowledge and beliefs about herb/supplement consumption and herb/supplement–drug interactions among the general population, including healthcare professionals and pharmacists: a systematic review and guidelines for a smart decision system. Nutrients. 2023;15(10):2298. https://doi.org/10.3390/nu15102298 DOI: https://doi.org/10.3390/nu15102298
19. Aslam K, Ali R, Rehmat R. Patterns of Supportive Medication Use Among Oncology Patients: A Cross-Sectional Study. J Biomol Pathog Ther. 2026;2(3):128-132. https://doi.org/10.68041/jbpt.v2i3/05 DOI: https://doi.org/10.68041/jbpt.v2i3/05
20. Ng CY, Zhao Y, Wang N, Chia KL, Teo CH, Peh W, et al. A multi-center cross-sectional study of Chinese herbal medicine–drug adverse reactions using active surveillance in Singapore’s traditional Chinese medicine clinics. Chin Med. 2024;19(1):44. https://doi.org/10.1186/s13020-024-00915-z DOI: https://doi.org/10.1186/s13020-024-00915-z
21. Alghamdi W, Al-Fadel N, Alghamdi EA, Alghamdi M, Alharbi F. Signal detection and assessment of herb–drug interactions: Saudi Food and Drug Authority experience. Drugs Real World Outcomes. 2023;10(4):577–585. https://doi.org/10.1007/s40801-023-00388-w DOI: https://doi.org/10.1007/s40801-023-00388-w
22. Hazra S, Singh PA. Safety aspects of herb interactions: current understanding and future prospects. Curr Drug Metab. 2024;25(1):28–53. https://doi.org/10.2174/0113892002289753240305062601 DOI: https://doi.org/10.2174/0113892002289753240305062601
23. Kavyani Z, Musazadeh V, Safaei E, Mohammadi Asmaroud M, Khashakichafi F, Sedgh Ahrabi S, et al. Antihypertensive effects of Nigella sativa supplementation: an updated systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2023;37(8):3224–3238. https://doi.org/10.1002/ptr.7891 DOI: https://doi.org/10.1002/ptr.7891
24. Fu Z, Lv J, Gao X, Zheng H, Shi S, Xu X, et al. Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials. BMC Complement Med Ther. 2023;23(1):260. https://doi.org/10.1186/s12906-023-04038-0 DOI: https://doi.org/10.1186/s12906-023-04038-0
25. Thikekar AK, Thomas AB, Chitlange SS. Herb–drug interactions in diabetes mellitus: a review based on pre-clinical and clinical data. Phytother Res. 2021;35(9):4763–4781. https://doi.org/10.1002/ptr.7108 DOI: https://doi.org/10.1002/ptr.7108
26. Woodford HJ. Polypharmacy in older patients. Br J Hosp Med (Lond). 2024;85(10):1–12. https://doi.org/10.12968/hmed.2024.0388 DOI: https://doi.org/10.12968/hmed.2024.0388
27. Saka SA, Oguntoyinbo ET. Concurrent use of herbal and prescribed medicines and the associated factors among the elderly with chronic diseases in Ogun State, Nigeria. West Afr J Pharm. 2026;37(1):149–160. https://doi.org/10.82351/wajp.vol37no1.444
28. Tsele-Tebakang T, Morris-Eyton H, Pretorius E. Concurrent use of herbal and prescribed medicine by patients in primary health care clinics, South Africa. Afr J Prim Health Care Fam Med. 2023;15(1). https://doi.org/10.4102/phcfm.v15i1.3829 DOI: https://doi.org/10.4102/phcfm.v15i1.3829
Published
Issue
Section
License
Copyright (c) 2026 Warda Javed, Kahifa Khan, Muneera Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Al-Najam Journal of Medical and Life Sciences (ANJMLS) follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC BY-NC license restricts the use of material for commercial purposes (Further details are available at website. The Editorial Board of the ANJMLS endeavors to ensure the accuracy, integrity, and quality of all published content. However, the responsibility of opinions, interpretations, and conclusions expressed in the published articles rests entirely with the authors and do not necessarily reflect the views of the Editorial Board, publisher, or affiliated institutions.
